SimmonsCooper
has the experience
and resources to
handle complex claims involving prescription medication.
Options: Email Bookmark Print Search PDF

Prescription Drugs & Medical Devices

When people have been injured by defective drugs or medical devices, SimmonsCooper has helped them stand up, speak out, and get the compensation they deserve.  We have a team of experienced attorneys, led by partner Tor Hoerman, that can handle your case and help you navigate the complicated world of pharmaceutical litigation.

Today, SimmonsCooper continues to work on the front lines of several groundbreaking pharmaceutical trials, including several on a national stage. We have represented thousands of pharmaceutical clients and recovered more than $100 million in verdicts and settlements.*

SimmonsCooper has experience in litigating complex medical matters. We have taken a leadership role in standing up for individuals who have been injured by dangerous or defective drugs

In pharmaceutical and medical device litigation, our success comes from our thorough understanding of our clients’ particular medical history, weighed against the manufacturers’ legal obligations for testing, warnings and labels.

We have concentrated practice areas in: 

        >  Vioxx
        >  Bextra
        >  Celebrex
        >  Ephedra and PPA
        >  Heart Devices
        >  Hormone Replacement Therapy (HRT)
        >  Ortho Evra

For more information about how we identify potentially dangerous drugs and to determine a manufacturer’s liability, click here.

* Please note that recovery results vary per client. The recovery amounts in each case reflect the specific facts of that case. Further, recovery amounts in past cases are not a guarantee of future results.

Resources for Clients

Prescription for Trouble
healthfinder Resources for Arthritis
Merck & Co., Inc.

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Medwatch
New England Journal of Medicine
American Heart Institute
American Stroke Association 

News

View All